Fox Chase Cancer Center News

PHILADELPHIA (August 6, 2019) – Patients with squamous cell carcinoma of the head and neck (HNSCC) may not benefit from high-dose postoperative radiation as compared with standard dosing, according to new research out of Fox Chase Cancer Center.

PHILADELPHIA (July 29, 2019) – Fox Chase Cancer Center has joined a network of leaders organizing across the healthcare industry to bring safety, equity and dignity to their workplaces for women by signing the TIME’S UP Healthcare commitment.

PHILADELPHIA (July 26, 2019) – Shuanzeng Wei, MD, PhD, and colleagues used SNP-based chromosome microarrays to analyze 14 tumor samples taken from patients with low-grade renal cell carcinoma with both clear cell and papillary features. This technology allowed them to perform genome-wide screening and identify genetic copy number variations at a much higher resolution than that of standard or high-resolution chromosome analysis.  

PHILADELPHIA (July 25, 2019) – Researchers at Fox Chase Cancer Center have found that Asf1 recognizes lysine 14 of histone H3 (H3K14) and facilitates the acetylation of H3K56 by the lysine acetyltransferase (KAT) Rtt019-Vps75.

PHILADELPHIA (July 23, 2019) – Fox Chase Cancer Center is pleased to announce the hiring of Fern Anari, MD, who will join the faculty as assistant professor in the Division of Genitourinary Medical Oncology within the Department of Hematology/Oncology.

PHILADELPHIA (July 22, 2019) – Researchers at Fox Chase Cancer Center have developed iSHARE, or Sexual Health and Augmenting Relationships through Education, a novel communication intervention to promote discussions about sexual health with breast cancer patients.

PHILADELPHIA (July 22, 2019) – Fox Chase Cancer Center is pleased to announce the hiring of Iberia Romina Sosa, MD, PhD, to the department of Hematology/Oncology.

Fox Chase Cancer Center community celebrated cancer survivorship on Saturday, July 13 as the Philadelphia Phillies played the Washington Nationals.